<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3790">
  <stage>Registered</stage>
  <submitdate>28/01/2013</submitdate>
  <approvaldate>28/01/2013</approvaldate>
  <nctid>NCT01781559</nctid>
  <trial_identification>
    <studytitle>Bioefficacy of Phenolic Acids</studytitle>
    <scientifictitle>Effect of Phenolic Acids on the Human Vasculature</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>11.35.NRC</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Endothelial Dysfunction</healthcondition>
  </conditions>
  <interventions>
    <interventions>Other interventions - phenolic acid

Experimental: phenolic acid + maltodextrin - phenolic acid + maltodextrin;

Placebo Comparator: Maltodextrin - Maltodextrin

Active Comparator: flavanol + maltodextrin - flavanol + maltodextrin


Other interventions: phenolic acid
phenolic acid

</interventions>
    <comparator />
    <control />
    <interventioncode>Other interventions interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change from predose in percent change of flow-mediated dilatation at 1h compared to control treatment</outcome>
      <timepoint>After 1 hour</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Change from predose in blood pressure at 0.5h</outcome>
      <timepoint>After 30 min</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Healthy, Men and women

          -  Subjects with endothelial dysfunction defined as a basal brachial artery flow-mediated
             dilatation (FMD) measurement between 3% and 8% at screening</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  Any food allergy

          -  Abnormal blood pressure defined as follow: systolic &lt;100 or &gt;160 mmHg and diastolic
             &lt;50 or &gt;100mmHg

          -  Pregnancy or lactating women

          -  Regular consumption of cholesterol-lowering or antihypertensive medication

          -  Smokers

          -  Inability to restrain from caffeine/tea and alcohol for 12hrs prior to study visits
             (intake1 day before screening measurements (and 1 day before each visit)

          -  Not restrain the intake of multivitamin-tablets and other supplemental compounds 10
             days before the study start and throughout the study.

          -  Excessive alcohol intake defined as &gt; 280 g per week for men and &gt;210g per week for
             women</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Supportive Care</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2>The people administering the treatment/s</masking2>
    <masking3>The people assessing the outcomes</masking3>
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/10/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>14</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/12/2013</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>School of Medicine and Pharmacology - University of WA - Perth</hospital>
    <postcode>6000 - Perth</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Nestl√©</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The objective is to demonstrate the effect of phenolic acids on endothelial function.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01781559</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kevin Croft, Professor</name>
      <address>School of Medicine and Pharmacology - University of WA</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>